European Journal of Cancer
Volume 33, Issue 5 , Pages 710-715 , April 1997

Multiple pathways to cellular senescence: Role of telomerase repressors

  • M. Oshimura

      Affiliations

    • Department of Molecular and Cell Genetics, School of Life Sciences, Faculty of Medicine, Tottori University, Nishimachi 86, Yonago, Tottori 683, Japan
    • Corresponding Author InformationCorrespondence to M. Oshimura.
  • ,
  • J.C. Barrett

      Affiliations

    • Laboratory of Molecular Carcinogenesis, NIEHS, P.O. Box 12233, Research Triangle Park, North Carolina 27709, U.S.A.

References 

  1. Saxon PJ, Srivatson ES, Leipzing GV, Sameshima JH, Stanbridge EJ. Selective transfer of individual human chromosomes to recipient cells. Mol Cell Biol. 1985;5:140–146
  2. Kugoh EM, Hashiba H, Shimizu M, Oshimura M. Suggestive evidence for functionally distinct, tumorsuppressor genes on chromosome 1 and 11 for a human fibrosarcoma cell line, HT1080. Oncogene. 1990;5:1637–1644
  3. London and Bristol, Taylor & Francis Oshimura M, Kugoh MH, Shimizu M, Yamada H, Horikawa I, Sasaki M. Multiple chromosomes carrying tumor suppressor activity, via microcellmediated chromosome transfer, for various tumour cell lines. In: Knudson AG, Stanbridge EJ, Sugimura T, Terada M, Watanabe S editor. Genetic Basis for Carcinogenesis, Tumour Suppressor Genes and Oncogenes. Tokyo: Jpn Sci Soc Press; 1990;p. 249–255
  4. Goyetee MC, Cho K, Fashing C, et al. Progression of colorectal cancer is associated with multiple tumour suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol Cell Biol. 1992;12:1387–1395
  5. Sasaki M, Honda T, Yamada H, Wake N, Barrett JC, Oshimura M. Evidence for multiple pathways to cellular senescence. Cancer Res. 1994;54:6090–6093
  6. Sugaware O, Oshimura M, Koi M, Annab LA, Barrett JC. Introduction of cellular senescence in immortalised cells by human chromosome 1. Science. 1990;247:707–710
  7. Kurimasa A, Nagata Y, Shimizu M, Emi M, Nakamura Y, Oshimura M. A human gene that restores the DNA-repair defect in SCID mice is located on 8p11.1-8q11.1. Hum Genet. 1994;93:21–26
  8. Oshimura M, Kurimasa A. Studies on tumour suppression by microcellmediated chromosome transfer. Cancer Chemother. 1992;7:52–54
  9. Ichikawa T, Nihei N, Kuramochi H, et al. Metastatic suppressor genes for prostate cancer. The Prostate Supplement. 1996;6:31–35
  10. Hayflick L. The cell biology of human aging. N Engl J Med. 1976;295:1302–1308
  11. Daniel CW, De Orne KB, Yung JT, Blair PB, Faulkin JJ. The in vivo span of normal and preneoplastic mouse mammary glands: a serial transplantation study. In: Proc Natl Acad Sci USA. 61:1968;p. 53–60
  12. Barrett JC. Cell senescence and apoptosis. In: Levine AJ, Schmideck HH editor. Molecular Genetics of Nervous System Tumours. New York: Wiley-Liss; 1993;p. 61–72
  13. Barrett JC, Ts'o POP. Evidence for the progressive nature of neoplastic transformation. In: Proc Natl Acad Sci USA. 75:1978;p. 3761–3765
  14. Barrett JC. A preneoplastic stage in the spontaneous neoplastic transformation of Syrian hamster embryo cells in culture. Cancer Res. 1980;40:91–94
  15. Newbold RF, Overell RW. Fibroblast immortality is a prerequisite for transformation of EJ c-Haras oncogene. Nature. 1983;304:648–651
  16. Pereira-Smith OM, Smith JR. Evidence for the recessive nature of cellular immortality. Science. 1983;221:964–966
  17. Ning Y, Weber JL, Killary AM, Ledbetter DH, Smith JR, Pereira-Smith OM. Genetic analysis of indefinite division in human cells: evidence for a cell senescencerelated gene (s) on human chromosome 4. In: Proc Natl Acad Sci USA. 8:1991;p. 5635–5639
  18. Koi M, Johnson LA, Kalikin LM, Little PFR, Nakamura Y, Feinberg AP. Tumour cell growth arrest caused by subchromosomal transferable DNA fragments from chromosome 11. Science. 1993;260:361–364
  19. Ogata T, Ayusawa D, Namba M, Takahashi E, Oshimura M, Oishi M. Chromosome 7 suppresses indefinite division of non-tumorigenic immortalised human fibroblast cell lines KMST-6 and SUSM-1. Mol Cell Biol. 1993;13:6036–6043
  20. Sandhu AK, Hubbard K, Kaur GP, Jha KK, Ozor HL, Athwal RS. Senescence of immortal human fibroblast by the introduction of normal human chromosome 6. In: Proc Natl Acad Sci USA. 91:1994;p. 5498–5502
  21. Yoshida MA, Shimizu M, Ikeuchi T, Tonomura A, Yokota J, Oshimura M. In vitro growth suppression and morphological change in a human renal cell carcinoma cell line by the introduction of normal chromosome 3 via microcell fusion. Mol Carcinogen. 1994;9:114–121
  22. Uejima H, Mitsuya K, Kugoh H, Horikawa I, Oshimura M. Normal human chromosome 2 induces cellular senescence in the human cervical carcinoma cell line SiHa. Genes Chromosomes Cancer. 1995;14:120–127
  23. Hensler PJ, Annab LA, Barrett JC, Pereira-Smith OM. A gene involved in the control of cellular senescence localised to human chromosome 1q. Mol Cell Biol. 1994;14:2291–2297
  24. Yamada H, Wake N, Fujimoto S, Barrett JC, Oshimura M. Multiple chromosomes carrying tumour supressor activity for a uterine endometrial carcinoma cell line identified by microcellmediated chromosome transfer. Oncogene. 1990;5:1141–1147
  25. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature. 1990;345:458–460
  26. Counter CM, Avilion AA, LeFeuvre CE, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 1992;11:1921–1929
  27. Lange TD. Activation of telomerase in a human tumour. In: Proc Natl Acad Sci USA. 91:1994;p. 2882–2885
  28. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011–2015
  29. Wright WE, Shay JW, Piatyszek M. Modification of a telomeric repeat amplification protocol (TRAP) results in increased reliability, linearity and sensitivity. Nucleic Acids Res. 1995;23:3794–3795
  30. Vojta PJ, Futreal PA, Annab LA, Kato H, Pereira-Smith OM, Barrett JC. Evidence for the two senescence loci on human chromosome 1. Genes Chromosomes Cancer. 1996;16:55–63
  31. Wright WE, Shay JW. The two-stage mechanism controlling cellular senescence and immortalisation. Exp Gerontol. 1992;27:383–389
  32. Moyer AW, Wallace R, Cox HR. Limited growth period of human lung cell lines transformed by simian virus 40. J Natl Cancer Inst. 1964;44:227–236
  33. Hubbard-Smith K, Patsalis P, Pardinas JR, Jha KK, Henderson AS, Ozer HL. Altered chromosome 6 in immortal human fibroblasts. Mol Cell Biol. 1992;12:2273–2281
  34. Goolsby CL, Wiley JE, Steiner M, Bartholdi MF, Cram LS, Kraemer PM. Karyotype evolution in a simian virus 40-transformed tumorigenic human cell line. Cancer Genet Cytogenet. 1991;49:231–248
  35. Hara E, Tsurui H, Shinozaki A, Nadada S, Oda K. Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts. Biochem Biophys Res Commun. 1991;179:528–534
  36. Thomassen DG, Barrett JC, Nettesheim P. Changes in stem cell populations of rat epithelial cell cultures at an early stage in neoplastic progression. Cancer Res. 1985;45:3322–3331
  37. Bols BL, Naaktgeboren JM, Simons JW. Immortalisation of Syrian hamster embryo cells is in itself a multistep event. Cancer Res. 1991;51:1177–1184
  38. Duncan EJ, Whitaker NJ, Moy EL, Reddel RR. Assignment of SV40-immortalised cells to more than one complementation group for immortalisation. Exp Cell Res. 1993;205:337–344
  39. Berry IJ, Burns JE, Parkinson EK. Assignment of two human epidermal squamous cell carcinoma cell lines to more than one complementation group for the immortal phenotype. Mol Carcinogen. 1994;9:134–142
  40. Blackburn EH. Structure and function of telomeres. Nature. 1991;350:569–573
  41. Allsopp RC, Vaziri H, Patterson C, et al. Telomere length predicts replicative capacity of human fibroblasts. In: Proc Natl Acad Sci USA. 89:1992;p. 10114–10118
  42. Ohmura H, Tahara H, Suzuki M, et al. Restoration of the cellular senescence programme and repression of telomerase by human chromosome 3. Jpn J Cancer Res. 1995;86:899–901
  43. Harley CB, Vaziri H, Counter CM, Allsopp RC. The telomere hypothesis of cellular aging. Exp Gerontol. 1992;27:375–382
  44. Shay JW, Tomlinson G, Piatyszek MA, Gollahon LS. Spontaneous in vitro immortalisation of breast epithelial cells from a patient with Li-Fraumeni syndrome. Mol Cell Biol. 1995;15:425–432
  45. Wright WE, Shay JW. Telomere positional effects and the regulation of cellular senescence. Trends Genet. 1992;8:193–197
  46. Goldstein S. Replicative senescence: the human fibroblast comes of age. Science. 1990;249:1129–1133
  47. Hayfiick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res. 1965;37:614–636
  48. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesises TTAGGG repeats. Cell. 1989;59:521–529
  49. Counter CM, Botelho FM, Wang P, Harley CB, Bacchetti S. Stabilisation of short telomeres and telomerase activity accompany immortalisation of Epstein-Barr virustransformed human B lymphocytes. J Virol. 1994;68:3410–3414
  50. Counter CM, Hirle HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma. In: Proc Natl Acad Sci USA. 91:1994;p. 2900–2904

PII: S0959-8049(97)00090-7

doi: 10.1016/S0959-8049(97)00090-7

European Journal of Cancer
Volume 33, Issue 5 , Pages 710-715 , April 1997